{"disease":{"id":"non-segmental-vitiligo","name":"non segmental vitiligo"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06072183","title":"A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1571,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT05583526","title":"A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":607,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06113445","title":"A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":467,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06113471","title":"A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT03715829","title":"A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04057573","title":"Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":344,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT04052425","title":"Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":330,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT04487860","title":"Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":327,"lead_sponsor_name":"Ache Laboratorios Farmaceuticos S.A.","has_results":true},{"nct_id":"NCT06804811","title":"A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT07431177","title":"A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07108283","title":"A Study of Zasocitinib in Adults With Nonsegmental Vitiligo","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06493578","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":false},{"nct_id":"NCT04927975","title":"Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06548360","title":"A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT04818346","title":"A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT06113328","title":"A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":169,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04811326","title":"Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Shaimaa Fawzy Abdel-rady Abdel-latif","has_results":false},{"nct_id":"NCT06511739","title":"A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"CSPC Ouyi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07172347","title":"Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Jiangsu vcare pharmaceutical technology co., LTD","has_results":false},{"nct_id":"NCT07058051","title":"Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT06991972","title":"Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Khyber Teaching Hospital","has_results":false},{"nct_id":"NCT07533019","title":"A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Eli Lilly and Company","has_results":false},{"nct_id":"NCT07437560","title":"Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hudson Biotech","has_results":false},{"nct_id":"NCT05750823","title":"A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT07223229","title":"Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Elixiron Immunotherapeutics (Hong Kong) Ltd.","has_results":false},{"nct_id":"NCT05316987","title":"Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT04942860","title":"The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Nicolaus Copernicus University","has_results":false},{"nct_id":"NCT03247400","title":"The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Nicolaus Copernicus University","has_results":false},{"nct_id":"NCT06619184","title":"Transplantation of Autologous Non-Cultured Extracted Hair Follicle Outer Root Sheath Cell Suspension and Mini Punch Graft for Stable Non-Segmental Vitiligo Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Universitas Padjadjaran","has_results":false},{"nct_id":"NCT07105254","title":"An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Derm Texas, PLLC","has_results":false}],"total":30},"guidelines":[],"source":"Drug Landscape verified database"}